Uterine Cancer Study Act of 2025
Officially: “Uterine Cancer Study Act of 2025” Read the full text
What it does
Read it in plain language
1Short title
This section would let the Act be called the "Uterine Cancer Study Act of 2025."
Show official text
1. Short title This Act may be cited as the Uterine Cancer Study Act of 2025 .
2Study on relationship between hair straighteners and uterine cancer
This section would direct the Secretary of Health and Human Services, working with the Commissioner of Food and Drugs and the Director of the National Institutes of Health, to study the relationship between hair straighteners and uterine cancer, with a focus on the increased incidence of the cancer among women of color. The study would have to review significant findings and recommendations from other studies on this relationship, consider impacts on women and other individuals at risk of uterine cancer from all racial and ethnic backgrounds, break down its results by whether the hair straighteners involved contain dyes or coloring, bleach, highlights, or perms, and determine whether the Food and Drug Administration should impose additional testing requirements on manufacturers of hair straightening products to ensure the products' safety. Within 45 days after the Act is enacted, the Secretary would have to submit a description of the study's methodology to the House Committee on Energy and Commerce and the Senate Committee on Health, Education, Labor, and Pensions. Within 180 days after enactment, the Secretary would have to begin the study. Within 2 years after enactment, the Secretary would have to complete the study and submit a report on its results to those same two committees. The section would define "hair straightener" as a chemical hair straightener, and "Secretary" as the Secretary of Health and Human Services.
Show official text
2. Study on relationship between hair straighteners and uterine cancer (a) Study The Secretary of Health and Human Services, in coordination with the Commissioner of Food and Drugs and the Director of the National Institutes of Health, shall conduct a study on the relationship between hair straighteners and uterine cancer, with a focus on the increased incidence of such cancer among women of color. Such study shall— (1) review significant findings and recommendations from other studies regarding the relationship between hair straighteners and uterine cancer; (2) consider impacts on women and other individuals at risk of uterine cancer from all racial and ethnic backgrounds; (3) disaggregate the results of the study under this section according to whether the hair straighteners contain dyes or coloring, bleach, highlights, or perms; and (4) determine whether the Food and Drug Administration should impose additional testing requirements on the manufacturers of hair straightening products to ensure the safety of such products. (b) Methodology Not later than 45 days after the date of enactment of this Act, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a description of the methodology that will be used to conduct the study under this section. (c) Commencement Not later than 180 days after the date of enactment of this Act, the Secretary shall commence the study under this section. (d) Report Not later than 2 years after the date of enactment of this Act, the Secretary shall complete the study under this section and submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on the results of such study. (e) Definition In this section: (1) The term hair straightener means a chemical hair straightener. (2) The term Secretary means the Secretary of Health and Human Services.
Where it is
In the House.